Your browser doesn't support javascript.
loading
A 15-day course of donepezil modulates spectral EEG dynamics related to target auditory stimuli in young, healthy adult volunteers.
Leroy, Christopher; Bourriez, Jean-Louis; Dujardin, Kathy; Molaee-Ardekani, Behnam; Babiloni, Claudio; Deplanque, Dominique; Ponchel, Amélie; Hennion, Sophie; Plomhause, Lucie; Devanne, Hervé; Deguil, Julie; Payoux, Pierre; Blin, Olivier; Méligne, Déborah; Micallef, Joëlle; Chauveau, Nicolas; Lanteaume, Laura; Vervueren, Céline; Guimont, François; Thalamas, Claire; Cassé-Perrot, Catherine; Rouby, Franck; Bordet, Régis; Derambure, Philippe.
Afiliación
  • Leroy C; INSERM U1171, Lille University Medical Center, Lille, France; Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France. Electronic address: christopher.leroy87@gmail.com.
  • Bourriez JL; INSERM U1171, Lille University Medical Center, Lille, France; Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France.
  • Dujardin K; INSERM U1171, Lille University Medical Center, Lille, France; Department of Neurology and Movement Disorders, Lille University Medical Center, Lille, France.
  • Molaee-Ardekani B; INSERM U1171, Lille University Medical Center, Lille, France; Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France.
  • Babiloni C; Department of Physiology and Pharmacology, University of Rome "La Sapienza", Rome, Italy; Department of Neuroscience, IRCCS San Raffaele Pisana, Rome, Italy.
  • Deplanque D; INSERM U1171, Lille University Medical Center, Lille, France; Department of Medical Pharmacology, Lille University Medical Center, Lille, France; CIC 1403 INSERM-CHU, Lille University Medical Center, Lille, France.
  • Ponchel A; INSERM U1171, Lille University Medical Center, Lille, France; Department of Medical Pharmacology, Lille University Medical Center, Lille, France.
  • Hennion S; INSERM U1171, Lille University Medical Center, Lille, France; Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France.
  • Plomhause L; INSERM U1171, Lille University Medical Center, Lille, France; Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France.
  • Devanne H; Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France; ULCO, Calais, France.
  • Deguil J; INSERM U1171, Lille University Medical Center, Lille, France; Department of Medical Pharmacology, Lille University Medical Center, Lille, France.
  • Payoux P; INSERM UMR 825 Brain Imaging and Neurological Dysfunctions, Toulouse, France.
  • Blin O; Department of Clinical Pharmacology, and CNRS UMR 7289, CIC-CPCET, Aix-Marseille University, Marseille, France.
  • Méligne D; INSERM UMR 825 Brain Imaging and Neurological Dysfunctions, Toulouse, France.
  • Micallef J; Department of Clinical Pharmacology, and CNRS UMR 7289, CIC-CPCET, Aix-Marseille University, Marseille, France.
  • Chauveau N; INSERM UMR 825 Brain Imaging and Neurological Dysfunctions, Toulouse, France.
  • Lanteaume L; Department of Clinical Pharmacology, and CNRS UMR 7289, CIC-CPCET, Aix-Marseille University, Marseille, France.
  • Vervueren C; INSERM UMR 825 Brain Imaging and Neurological Dysfunctions, Toulouse, France.
  • Guimont F; Department of Clinical Pharmacology, and CNRS UMR 7289, CIC-CPCET, Aix-Marseille University, Marseille, France.
  • Thalamas C; Department of Medical Pharmacology, INSERM CIC 1436, Toulouse University Medical Center, Toulouse, France.
  • Cassé-Perrot C; Department of Clinical Pharmacology, and CNRS UMR 7289, CIC-CPCET, Aix-Marseille University, Marseille, France.
  • Rouby F; Department of Clinical Pharmacology, and CNRS UMR 7289, CIC-CPCET, Aix-Marseille University, Marseille, France.
  • Bordet R; INSERM U1171, Lille University Medical Center, Lille, France; Department of Medical Pharmacology, Lille University Medical Center, Lille, France.
  • Derambure P; INSERM U1171, Lille University Medical Center, Lille, France; Department of Clinical Neurophysiology, Lille University Medical Center, Lille, France.
Clin Neurophysiol ; 130(5): 863-875, 2019 05.
Article en En | MEDLINE | ID: mdl-26699666
ABSTRACT

OBJECTIVE:

To identify possible electroencephalographic (EEG) markers of donepezil's effect on cortical activity in young, healthy adult volunteers at the group level.

METHODS:

Thirty subjects were administered a daily dose of either 5mg donepezil or placebo for 15days in a double-blind, randomized, cross-over trial. The electroencephalogram during an auditory oddball paradigm was recorded from 58 scalp electrodes. Current source density (CSD) transformations were applied to EEG epochs. The event-related potential (ERP), inter-trial coherence (ITC the phase consistency of the EEG spectrum) and event-related spectral perturbation (ERSP the EEG power spectrum relative to the baseline) were calculated for the target (oddball) stimuli.

RESULTS:

The donepezil and placebo conditions differed in terms of the changes in delta/theta/alpha/beta ITC and ERSP in various regions of the scalp (especially the frontal electrodes) but not in terms of latency and amplitude of the P300-ERP component.

CONCLUSION:

Our results suggest that ITC and ERSP analyses can provide EEG markers of donepezil's effects in young, healthy, adult volunteers at a group level.

SIGNIFICANCE:

Novel EEG markers could be useful to assess the therapeutic potential of drug candidates in Alzheimer's disease in healthy volunteers prior to the initiation of Phase II/III clinical studies in patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Encéfalo / Nootrópicos / Potenciales Evocados / Donepezilo Tipo de estudio: Clinical_trials Límite: Adult / Humans / Male Idioma: En Revista: Clin Neurophysiol Asunto de la revista: NEUROLOGIA / PSICOFISIOLOGIA Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Encéfalo / Nootrópicos / Potenciales Evocados / Donepezilo Tipo de estudio: Clinical_trials Límite: Adult / Humans / Male Idioma: En Revista: Clin Neurophysiol Asunto de la revista: NEUROLOGIA / PSICOFISIOLOGIA Año: 2019 Tipo del documento: Article